Skip to content

News & Resources

Since Cure HHT was established 25 years ago, we have been dedicated to providing answers to every question we can about HHT for patients, caregivers, doctors and researchers. Cure HHT remains the primary source for the most recent and reliable information about Hereditary Hemorrhagic Telangiectasia.

Cure HHT Leads Global Breakthrough in Bleeding Standards, Paving the Way for Future HHT Therapies

Cure HHT Leads Global Breakthrough in Bleeding Standards, Paving the Way for Future HHT Therapies

A newly published international consensus report—developed under the leadership of Cure HHT, the only nonprofit organization in the world dedicated to funding global research, awareness,...
Newsletter-Spring25-pazopanib3

A History of Pazopanib

There are no FDA-approved therapeutics for the treatment of HHT. Cure HHT sought to change that. In many ways, the history of pazopanib is not...
Copy of Breaking (Instagram Post)

This Landmark HHT Study Could Shift National Attention

We’re excited to share some truly important news for the HHT community. A major new study done in collaboration between Cure HHT, Massachusetts General Hospital,...

Cure HHT is happy to provide a wide array of resources for patients, families, physicians and researchers. Be sure to check out our extensive resource library that houses fact sheets, brochures, publications, and all of our educational webinars.

Treatment Centers Header Image

With an entire team of dedicated specialists to coordinate care, the HHT Treatment Centers of Excellence are the best place to access expert HHT care.

notebook-2386034_1920

See what webinars we have coming up so you can watch them LIVE and get your questions answered in real time! You can also view our past webinars, with topics including (but not limited to!) insurance, AVMs, research, genetics, and children with HHT.

Scroll To Top